Françoise Brée
Impact in
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
- Neurology top 10%
- Barrier Structure and Function Studies
Papers in
-
- Pharmacogenetics and Drug Metabolism 6
- Antibiotics Pharmacokinetics and Efficacy 5
-
- Analytical Methods in Pharmaceuticals 6
- Co-authors
- Bernard TestaJean‐Paul TillementSaı̈k UrienRoméo CecchelliPierre‐Alain CarruptMarie‐Pierre DehouckJean‐Charles FruchartRoland Zini
- Journals
- Biochemical Pharmacology (6 papers)Biochemical Journal (4 papers)Journal of Cardiovascular Pharmacology (2 papers)Life Sciences (2 papers)Helvetica Chimica Acta (2 papers)
- Partner nations
- FranceSwitzerlandJapan
In The Last Decade
Françoise Brée
54 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 118
- Biochemistry 108
- Neurology 121
- Pharmacology 121
- Pharmacology 179
- Spectroscopy 171
Countries citing papers authored by Françoise Brée
This map shows the geographic impact of Françoise Brée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Brée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Brée more than expected).
Fields of papers citing papers by Françoise Brée
This network shows the impact of papers produced by Françoise Brée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Brée. The network helps show where Françoise Brée may publish in the future.
Co-authors
The 25 scholars most cited alongside Françoise Brée, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 0 | |
| 2 | 2012 | 5 | |
| 3 | 2002 | 17 | |
| 4 | 2002 | 48 | |
| 5 | 1998 | 158 | |
| 6 | 1997 | 14 | |
| 7 | 1996 | 35 | |
| 8 | 1993 | 22 | |
| 9 | 1993 | 9 | |
| 10 | 1992 | 2 | |
| 11 | 1992 | 252 | |
| 12 | 1990 | 7 | |
| 13 | 1990 | 20 | |
| 14 | 1989 | 12 | |
| 15 | Binding to alpha 1-acid glycoprotein and relevant apparent volume of distribution. | 1989 | 5 |
| 16 | 1989 | 14 | |
| 17 | 1988 | 15 | |
| 18 | 1988 | 35 | |
| 19 | 1987 | 5 | |
| 20 | [Pharmacokinetics and bioavailability of alizapride (author's transl)]. | 1982 | 1 |
About Françoise Brée
Françoise Brée is a scholar working on Pharmacology, Analytical Chemistry, Spectroscopy, Pharmacology and Oncology, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include Analytical Chemistry and Chromatography (10 papers), Protein Interaction Studies and Fluorescence Analysis (10 papers), Drug Transport and Resistance Mechanisms (8 papers), Pharmacogenetics and Drug Metabolism (6 papers), Analytical Methods in Pharmaceuticals (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Pharmaceutical studies and practices (4 papers) and Receptor Mechanisms and Signaling (4 papers). The work is most often cited by research in Biochemistry (108 citations), Neurology (121 citations), Pharmacology (121 citations), Pharmacology (179 citations) and Spectroscopy (171 citations). Françoise Brée has collaborated with scholars based in France, Switzerland and Japan. Frequent co-authors include Bernard Testa, Jean‐Paul Tillement, Jean‐Paul Tillement, Saı̈k Urien, Roméo Cecchelli, Pierre‐Alain Carrupt, Marie‐Pierre Dehouck, Jean‐Charles Fruchart, Roland Zini and J P Tillement. Their work appears in journals such as Biochemical Pharmacology, Biochemical Journal, Journal of Cardiovascular Pharmacology, Life Sciences and Helvetica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.